J. Seldomridge

发表

Phase II Study of Paclitaxel, Carboplatin, and Cetuximab as First Line Treatment, for Patients with Advanced Non-small Cell Lung Cancer (NSCLC): Results of OPN-017

M. Millenson, S. Litwin, H. Borghaei, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Promising Survival in Patients with Recurrent Non-small Cell Lung Cancer Treated with Docetaxel and Gemcitabine in Combination as Second-Line Therapy

M. Millenson, H. Borghaei, C. Langer, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.